Continuous hyperfractionated accelerated radiotherapy weekend-less (CHARTWEL) in non small-cell lung cancer (NSCLC)

被引：0
|
作者：
Roth, BM
Bonomi, MR
Cerchetti, L
Pogany, C
Zaderajko, M
Brosio, C
机构：
来源：
RADIOLOGY | 2001年 / 221卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：173 / 174
页数：2
相关论文
共 50 条
  • [1] Experience with dose escalation using CHARTWEL (continuous hyperfractionated accelerated radiotherapy weekend less) in non small cell lung cancer
    Saunders, MI
    Rojas, A
    Lyn, BE
    Pigott, K
    Powell, M
    Goodchild, K
    Hoskin, PJ
    Phillips, H
    Verma, N
    BRITISH JOURNAL OF CANCER, 1998, 78 (10) : 1323 - 1328
  • [2] Neoadjuvant chemotherapy & continuous hyperfractionated accelerated radiotherapy, weekend less (CHARTWEL) in non-small cell lung cancer.
    Sibtain, A
    Rojas, A
    Lyn, BE
    Hoskin, PJ
    Shah, N
    Saunders, MI
    BRITISH JOURNAL OF CANCER, 1999, 80 : 15 - 15
  • [3] Experience with dose escalation using CHARTWEL (continuous hyperfractionated accelerated radiotherapy weekend less) in non-small-cell lung cancer
    MI Saunders
    A Rojas
    BE Lyn
    K Pigott
    M Powell
    K Goodchild
    PJ Hoskin
    H Phillips
    N Verma
    British Journal of Cancer, 1998, 78 : 1323 - 1328
  • [4] Continuous hyperfractionated accelerated radiotherapy - weekend less (CHARTWEL) versus conventionally fractionated (CF) radiotherapy in non-small-cell lung cancer (NSCLC): first results of a phase III randomised multicentre trial (ARO 97-1)
    Baumann, M.
    Herrmann, T.
    Koch, R.
    Wahlers, B.
    Kepka, L.
    Marschke, G.
    Feltl, D.
    Fietkau, R.
    Budach, V.
    Dunst, J.
    EJC SUPPLEMENTS, 2005, 3 (02): : 323 - 323
  • [5] Continuous hyperfractionated accelerated radiotherapy in non-small cell lung cancer
    Ivanova, Irina N.
    Gulidov, Igor A.
    Kudrjavtsev, Dmitry, V
    Zolotkov, Alexey G.
    Kursova, Larisa, V
    Ragulin, Yury A.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S955 - S955
  • [6] Effectiveness and Tolerability of hyperfractionated accelerated Radiotherapy for non-small cell Lung Cancer (NSCLC)
    Utz, D.
    Gani, C.
    Heinzelmann, F.
    Viehrig, M.
    Welz, S.
    Zips, D.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (SUPPL 1) : S148 - S149
  • [7] 10 years of CHART (continuous hyperfractionated accelerated radiotherapy) for non-small cell lung cancer (NSCLC) at NCCC
    Pickles, R. L.
    Iqbal, S.
    Mulvenna, P.
    Mcmenemin, R.
    Kelly, E.
    Atherton, P.
    Turnbull, H.
    Simmons, T.
    Bradshaw, A.
    Mackenzie, L.
    Raven, E.
    LUNG CANCER, 2016, 91 : S50 - S50
  • [8] Lung and oesophageal morbidity following 3D conformal radiotherapy for non-small cell lung cancer (NSCLC) treated with chart weekend less (CHARTWEL)
    Wilson, E
    Lyn, E
    Williams, J
    RADIOTHERAPY AND ONCOLOGY, 2003, 68 : S121 - S121
  • [9] Continuous hyperfractionated accelerated radiotherapy (CHART) for non-small cell lung cancer (NSCLC) in patients age 80 and above
    Iqbal, M. S.
    Hassani, A.
    Kelly, E.
    Veeratterapillay, J.
    Mackenzie, L.
    Pickles, R.
    LUNG CANCER, 2018, 115 : S71 - S71
  • [10] Hyperfractionated and accelerated radiotherapy in non-small cell lung cancer
    Haslett, Kate
    Poettgen, Christoph
    Stuschke, Martin
    Faivre-Finn, Corinne
    JOURNAL OF THORACIC DISEASE, 2014, 6 (04) : 328 - 335
12345